For the treatment of psychoses, such as acute and chronic schizophrenic disorders, in which positive symptoms (e.g., delusions, hallucinations, thought disorders) and/or negative symptoms (e.g., blunted affect, emotional and social withdrawal) are prominent, including patients characterized by predominant negative symptoms.